Cardiovascular Comorbidities in Chronic Obstructive Pulmonary Disease (COPD)-Current Considerations for Clinical...

Area of Science:

• Cardiology
• Pulmonology
• Internal Medicine

Background:

• Cardiovascular comorbidities are highly prevalent in patients with chronic obstructive pulmonary disease (COPD).
• These comorbidities significantly contribute to morbidity and mortality in COPD patients.
• The relationship is increasingly viewed as a "cardiopulmonary continuum" beyond shared risk factors like smoking.

Purpose of the Study:

• To highlight the prevalence and impact of cardiovascular comorbidities in COPD.
• To emphasize the need for an integrated diagnostic and therapeutic approach.
• To advocate for refined phenotyping in managing these co-occurring diseases.

Main Methods:

• Review of current understanding of the cardiopulmonary continuum.
• Analysis of diagnostic challenges due to overlapping symptoms (e.g., dyspnea, chest pain).
• Evaluation of treatment implications, including medication hesitancy.

Main Results:

• Overlapping symptoms can lead to missed diagnoses and a worse prognosis.
• Concerns about side effects may lead to under-treatment of cardiovascular conditions.
• Current guidelines often focus on individual diseases, neglecting the integrated perspective.

Conclusions:

• An integrative perspective is crucial for future diagnostic and therapeutic strategies in COPD patients with cardiovascular comorbidities.
• Refined phenotyping of disease entities is essential for personalized management.
• Addressing the cardiopulmonary continuum can improve patient outcomes and reduce mortality.